Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark W Kroll. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Mark W Kroll has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:HAE / Haemonetics Corporation Director 23,357
US:AXON / Axon Enterprise, Inc. Director 11,135
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark W Kroll. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases HAE / Haemonetics Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HAE / Haemonetics Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HAE / Haemonetics Corporation Insider Trades
Insider Sales HAE / Haemonetics Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HAE / Haemonetics Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2022-08-15 HAE KROLL MARK W 8,016 73.7100 8,016 73.7100 590,859 43 72.0500 -13,306 -2.25
2021-05-26 HAE KROLL MARK W 11,813 55.1000 11,813 55.1000 650,896
2018-01-02 HAE KROLL MARK W 7,118 63.0000 7,118 63.0000 448,434
2017-05-15 HAE KROLL MARK W 100 41.4400 100 41.4400 4,144
2017-05-15 HAE KROLL MARK W 100 41.4450 100 41.4450 4,144
2017-05-15 HAE KROLL MARK W 200 41.4500 200 41.4500 8,290
2017-05-15 HAE KROLL MARK W 53 41.4510 53 41.4510 2,197
2017-05-15 HAE KROLL MARK W 100 41.4580 100 41.4580 4,146
2017-05-15 HAE KROLL MARK W 500 41.4600 500 41.4600 20,730
2017-05-15 HAE KROLL MARK W 300 41.4650 300 41.4650 12,440
2017-05-15 HAE KROLL MARK W 1,771 41.4700 1,771 41.4700 73,443
2017-05-15 HAE KROLL MARK W 300 41.4750 300 41.4750 12,442
2017-05-15 HAE KROLL MARK W 1,900 41.4800 1,900 41.4800 78,812
2017-05-15 HAE KROLL MARK W 300 41.4850 300 41.4850 12,446
2017-05-15 HAE KROLL MARK W 100 41.4900 100 41.4900 4,149
2017-05-15 HAE KROLL MARK W 100 41.4950 100 41.4950 4,150
2017-05-15 HAE KROLL MARK W 453 41.5000 453 41.5000 18,800
2017-05-15 HAE KROLL MARK W 276 41.5050 276 41.5050 11,455
2017-05-15 HAE KROLL MARK W 818 41.5200 818 41.5200 33,963
2017-05-15 HAE KROLL MARK W 129 41.5300 129 41.5300 5,357
2017-05-15 HAE KROLL MARK W 273 41.5400 273 41.5400 11,340
2017-05-15 HAE KROLL MARK W 100 41.5480 100 41.5480 4,155
2017-05-15 HAE KROLL MARK W 400 41.5500 400 41.5500 16,620
2017-05-15 HAE KROLL MARK W 307 41.5600 307 41.5600 12,759
2015-02-27 HAE KROLL MARK W 11,328 44.7990 11,328 44.7990 507,483
2012-11-19 HAE KROLL MARK W 4,592 80.1300 4,592 80.1300 367,957
2012-11-16 HAE KROLL MARK W 6,000 79.6721 6,000 79.6721 478,033
2012-05-04 HAE KROLL MARK W 20,000 71.0881 20,000 71.0881 1,421,762

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HAE / Haemonetics Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Mark W Kroll as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-25 2025-07-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,693 23,357 13.03
2024-07-26 2024-07-25 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,207 20,664 11.96
2023-08-08 2023-08-04 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,226 18,457 13.71
2023-05-15 2023-05-12 4 AXON AXON ENTERPRISE, INC.
Common Stock
A - Award 993 11,135 9.79
2023-03-08 2023-03-07 4 AXON AXON ENTERPRISE, INC.
Common Stock
S - Sale -3,457 10,142 -25.42 220.72 -763,043 2,238,583
2023-03-08 2023-03-07 4 AXON AXON ENTERPRISE, INC.
Common Stock
S - Sale -92 13,599 -0.67 220.85 -20,318 3,003,339
2022-08-16 2022-08-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -8,016 16,231 -33.06 73.71 -590,859 1,196,387
2022-08-08 2022-08-05 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,730 24,247 12.69
2022-06-09 2022-06-08 4 AXON AXON ENTERPRISE, INC.
Common Stock
S - Sale -3,159 13,691 -18.75 102.82 -324,796 1,407,654
2022-05-23 2022-05-20 4 AXON AXON ENTERPRISE, INC.
Common Stock
A - Award 2,013 16,850 13.57 99.40 200,092 1,674,890
2021-08-09 2021-08-06 4 HAE HAEMONETICS CORP
Common Stock
A - Award 3,077 21,517 16.69
2021-06-01 2021-05-27 4 AXON AXON ENTERPRISE, INC.
Common Stock
A - Award 1,434 14,837 10.70 139.48 200,014 2,069,465
2021-05-28 2021-05-26 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise -10,353 0 -100.00
2021-05-28 2021-05-26 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -11,813 18,440 -39.05 55.10 -650,896 1,016,044
2021-05-28 2021-05-26 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 10,353 30,253 52.03 35.50 367,557 1,074,057
2021-05-14 2021-05-12 4 AXON AXON ENTERPRISE, INC.
Common Stock
S - Sale -4,204 13,403 -23.88 124.94 -525,260 1,674,611
2021-05-14 2020-09-14 5 HAE HAEMONETICS CORP
Common Stock
G - Gift -167 19,900 -0.83
2021-05-14 2020-09-11 5 HAE HAEMONETICS CORP
Common Stock
G - Gift -334 20,067 -1.64
2021-01-21 2021-01-19 4 AAXN AXON ENTERPRISE, INC.
Common Stock
G - Gift -1,000 17,607 -5.37
2020-11-17 2020-11-16 4 AAXN AXON ENTERPRISE, INC.
Common Stock
S - Sale -2,993 18,607 -13.86 120.44 -360,477 2,241,027
2020-07-22 2020-07-21 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,983 20,401 10.77
2020-06-02 2020-05-29 4 AAXN AXON ENTERPRISE, INC.
Common Stock
A - Award 2,107 21,600 10.81 75.96 160,048 1,640,736
2020-04-13 2020-04-09 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise X -6,573 0 -100.00
2020-04-13 2020-04-09 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4,329 18,418 -19.03 102.00 -441,558 1,878,636
2020-04-13 2020-04-09 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -6,573 22,747 -22.42 102.00 -670,446 2,320,194
2020-04-13 2020-04-09 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 6,573 29,320 28.90 45.45 298,743 1,332,594
2020-04-13 2019-12-31 4 HAE HAEMONETICS CORP
Common Stock
G - Gift -870 22,747 -3.68
2019-11-14 2019-11-13 4 AAXN AXON ENTERPRISE, INC.
Common Stock
S - Sale -4,168 19,493 -17.62 64.30 -267,987 1,253,330
2019-07-26 2019-07-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,460 23,617 6.59
2019-06-03 2019-05-31 4 AAXN AXON ENTERPRISE, INC.
Common Stock
A - Award 2,396 23,661 11.27 66.78 160,005 1,580,082
2019-05-24 2019-05-21 4 HAE HAEMONETICS CORP
Common Stock
G - Gift -1,449 22,157 -6.14
2019-05-22 2019-05-20 4 AAXN AXON ENTERPRISE, INC.
Common Stock
G - Gift -952 21,265 -4.29
2019-05-13 2018-12-24 5 HAE HAEMONETICS CORP
Common Stock
G - Gift -1,142 23,606 -4.61
2018-11-09 2018-11-07 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise X -8,196 0 -100.00
2018-11-09 2018-11-07 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10,707 24,748 -30.20 114.00 -1,220,598 2,821,272
2018-11-09 2018-11-07 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 8,196 35,455 30.07 36.37 298,089 1,289,498
2018-11-09 2018-08-16 4 HAE HAEMONETICS CORP
Common Stock
G - Gift -200 27,259 -0.73
2018-11-09 2018-08-14 4 HAE HAEMONETICS CORP
Common Stock
G - Gift -1,000 27,459 -3.51
2018-08-29 2018-08-28 4 AAXN AXON ENTERPRISE, INC.
Common Stock
G - Gift -1,888 22,217 -7.83
2018-08-20 2018-08-20 4 AAXN AXON ENTERPRISE, INC.
Common Stock
S - Sale -7,097 24,105 -22.75 64.34 -456,621 1,550,916
2018-07-30 2018-07-26 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,696 28,459 6.34
2018-06-29 2014-12-16 4 AAXN AXON ENTERPRISE, INC.
Common Stock
S - Sale -3,100 31,202 -9.04 22.85 -70,835 712,966
2018-06-29 2013-06-07 4 AAXN AXON ENTERPRISE, INC.
Common Stock
G - Gift -2,070 55,135 -3.62 9.43 -19,520 519,923
2018-05-24 2018-05-24 4 AAXN AXON ENTERPRISE, INC.
Common Stock
A - Award 2,577 57,205 4.72 62.08 159,980 3,551,286
2018-01-03 2018-01-02 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise -7,118 0 -100.00
2018-01-03 2018-01-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -7,118 26,763 -21.01 63.00 -448,434 1,686,069
2018-01-03 2018-01-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 7,118 33,881 26.60 34.40 244,895 1,165,676
2017-07-31 2017-07-27 4 HAE HAEMONETICS CORP
Common Stock
A - Award 4,329 26,763 19.30 39.27 170,000 1,050,983
2017-05-26 2017-05-25 4 AAXN AXON ENTERPRISE, INC.
Common Stock
A - Award 6,403 54,628 13.28 24.99 160,011 1,365,154
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise -8,580 0 -100.00
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -307 22,434 -1.35 41.56 -12,759 932,357
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -400 22,741 -1.73 41.55 -16,620 944,889
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -100 23,141 -0.43 41.55 -4,155 961,462
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -273 23,241 -1.16 41.54 -11,340 965,431
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -129 23,514 -0.55 41.53 -5,357 976,536
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -818 23,643 -3.34 41.52 -33,963 981,657
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -276 24,461 -1.12 41.50 -11,455 1,015,254
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -453 24,737 -1.80 41.50 -18,800 1,026,586
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -100 25,190 -0.40 41.50 -4,150 1,045,259
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -100 25,290 -0.39 41.49 -4,149 1,049,282
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -300 25,390 -1.17 41.48 -12,446 1,053,304
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -1,900 25,690 -6.89 41.48 -78,812 1,065,621
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -300 27,590 -1.08 41.48 -12,442 1,144,295
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -1,771 27,890 -5.97 41.47 -73,443 1,156,598
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -300 29,661 -1.00 41.46 -12,440 1,229,893
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -500 29,961 -1.64 41.46 -20,730 1,242,183
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -100 30,461 -0.33 41.46 -4,146 1,262,852
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -53 30,561 -0.17 41.45 -2,197 1,266,784
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -200 30,614 -0.65 41.45 -8,290 1,268,950
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -100 30,814 -0.32 41.44 -4,144 1,277,086
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -100 30,914 -0.32 41.44 -4,144 1,281,076
2017-05-17 2017-05-15 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 8,580 31,014 38.25 27.24 233,719 844,821
2016-07-25 2016-07-21 4 HAE HAEMONETICS CORP
Common Stock
A - Award 5,746 22,478 34.34 29.58 169,995 665,012
2016-05-27 2016-05-26 4 TASR TASER INTERNATIONAL INC
Common Stock
A - Award 3,633 48,225 8.15 22.02 79,999 1,061,914
2015-07-23 2015-07-21 4 HAE HAEMONETICS CORP
Common Stock
A - Award 4,337 16,732 34.99
2015-05-20 2015-05-18 4 TASR TASER INTERNATIONAL INC
Common Stock
A - Award 2,467 44,592 5.86
2015-05-11 2015-05-08 4 TASR TASER INTERNATIONAL INC
Employee Stock Option
M - Exercise -22,026 0 -100.00 4.54 -99,998
2015-05-11 2015-05-08 4 TASR TASER INTERNATIONAL INC
Director Stock Option
M - Exercise -23,041 0 -100.00 4.34 -99,998
2015-05-11 2015-05-08 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -45,067 42,125 -51.69 31.39 -1,414,653 1,322,304
2015-05-11 2015-05-08 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 22,026 87,192 33.80 4.54 99,998 395,852
2015-05-11 2015-05-08 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 23,041 65,166 54.70 4.34 99,998 282,820
2015-03-03 2015-02-27 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -11,328 0 -100.00 44.80 -507,483
2015-03-03 2015-02-27 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -11,328 12,395 -47.75 44.80 -507,483 555,284
2015-03-03 2015-02-27 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 11,328 23,723 91.39 29.23 331,117 693,423
2014-11-03 2014-11-03 4 TASR TASER INTERNATIONAL INC
Director Stock Option
M - Exercise -13,870 0 -100.00 7.21 -100,003
2014-11-03 2014-11-03 4 TASR TASER INTERNATIONAL INC
Director Stock Option
M - Exercise -3,972 0 -100.00 10.07 -39,998
2014-11-03 2014-11-03 4 TASR TASER INTERNATIONAL INC
Director Stock Option
M - Exercise -4,175 0 -100.00 9.58 -39,996
2014-11-03 2014-11-03 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -22,017 42,125 -34.33 18.62 -409,957 784,368
2014-11-03 2014-11-03 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 13,870 64,142 27.59 7.21 100,003 462,464
2014-11-03 2014-11-03 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 3,972 50,272 8.58 10.07 39,998 506,239
2014-11-03 2014-11-03 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 4,175 46,300 9.91 9.58 39,996 443,554
2014-07-25 2014-07-23 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 10,353 10,353
2014-07-25 2014-07-23 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,394 12,395 23.94
2014-05-19 2014-05-15 4 TASR TASER INTERNATIONAL INC
Common Stock
A - Award 6,130 42,125 17.03
2014-03-04 2014-02-28 4 TASR TASER INTERNATIONAL INC
Director Stock Option
M - Exercise -12,000 0 -100.00 8.81 -105,720
2014-03-04 2014-02-28 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -12,000 35,995 -25.00 20.00 -240,000 719,900
2014-03-04 2014-02-28 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 12,000 47,995 33.34 8.81 105,720 422,836
2013-12-17 2013-12-16 4 TASR TASER INTERNATIONAL INC
Director Stock Option
M - Exercise -12,000 0 -100.00 8.81 -105,720
2013-12-17 2013-12-16 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -12,000 35,995 -25.00 17.10 -205,200 615,514
2013-12-17 2013-12-16 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 12,000 47,995 33.34 8.81 105,720 422,836
2013-09-06 2013-09-05 4 TASR TASER INTERNATIONAL INC
Director Stock Option
M - Exercise -23,810 0 -100.00 4.20 -100,002
2013-09-06 2013-09-05 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -23,810 35,995 -39.81 12.32 -293,339 443,458
2013-09-06 2013-09-05 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 23,810 59,805 66.15 4.20 100,002 251,181
2013-07-26 2013-07-24 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 6,573 6,573
2013-07-26 2013-07-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,649 10,001 19.74
2013-07-15 2013-05-23 4 TASR TASER INTERNATIONAL INC
Common Stock
A - Award 5,862 35,995 19.45
2012-11-21 2012-11-19 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -4,592 0 -100.00
2012-11-21 2012-11-19 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -4,592 4,176 -52.37 80.13 -367,957 334,623
2012-11-21 2012-11-19 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 4,592 8,768 109.96 49.92 229,233 437,699
2012-11-20 2012-11-16 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -6,000 0 -100.00
2012-11-20 2012-11-16 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -6,000 4,176 -58.96 79.67 -478,033 332,711
2012-11-20 2012-11-16 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 6,000 10,176 143.68 52.76 316,560 536,886
2012-08-20 2012-08-20 4 TASR TASER INTERNATIONAL INC
Employee Stock Option (Right to Buy)
M - Exercise -26,666 0 -100.00 0.32 -8,533
2012-08-20 2012-08-20 4 TASR TASER INTERNATIONAL INC
Employee Stock Option(Right to Buy)
M - Exercise -14,963 0 -100.00 0.37 -5,536
2012-08-20 2012-08-20 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -26,666 30,133 -46.95 5.41 -144,143 162,884
2012-08-20 2012-08-20 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 26,666 30,133 769.14 0.32 8,533 9,643
2012-08-20 2012-08-20 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -14,963 30,133 -33.18 5.41 -80,882 162,884
2012-08-20 2012-08-20 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 14,963 30,133 98.64 0.37 5,536 11,149
2012-08-20 2012-08-17 4 TASR TASER INTERNATIONAL INC
Employee Stock Option (Right to Buy)
M - Exercise -45,037 0 -100.00 0.37 -16,664
2012-08-20 2012-08-17 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise -45,037 30,133 -59.91 5.47 -246,560 164,966
2012-08-20 2012-08-17 4 TASR TASER INTERNATIONAL INC
Common Stock
M - Exercise 45,037 30,133 -302.18 0.37 16,664 11,149
2012-07-31 2012-07-27 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 4,098 4,098
2012-07-31 2012-07-27 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,031 4,176 32.78 0.01 10 42
2012-06-01 2012-05-31 4 TASR TASER INTERNATIONAL INC
Common Stock
A - Award 9,300 30,133 44.64
2012-05-08 2012-05-04 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -20,000 0 -100.00 71.09 -1,421,762
2012-05-08 2012-05-04 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -20,000 3,145 -86.41 71.09 -1,421,762 223,572
2012-05-08 2012-05-04 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 20,000 23,145 635.93 48.76 975,300 1,128,666
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)